385 related articles for article (PubMed ID: 18550199)
21. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects.
Sebeková K; Krivošíková Z; Gajdoš M
Clin Chem Lab Med; 2014 Jan; 52(1):139-49. PubMed ID: 23509221
[TBL] [Abstract][Full Text] [Related]
22. Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients.
Piarulli F; Lapolla A; Ragazzi E; Susana A; Sechi A; Nollino L; Cosma C; Fedele D; Sartore G
Atherosclerosis; 2013 Jan; 226(1):252-7. PubMed ID: 23182189
[TBL] [Abstract][Full Text] [Related]
23. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
24. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
[TBL] [Abstract][Full Text] [Related]
25. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness.
Choi KM; Yoo HJ; Kim HY; Lee KW; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
Int J Cardiol; 2009 Feb; 132(1):96-101. PubMed ID: 18190981
[TBL] [Abstract][Full Text] [Related]
26. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Busch M; Franke S; Stein G; Wolf G;
Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
[TBL] [Abstract][Full Text] [Related]
27. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
28. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
[TBL] [Abstract][Full Text] [Related]
29. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Willemsen S; Hartog JW; van Veldhuisen DJ; van der Meer P; Roze JF; Jaarsma T; Schalkwijk C; van der Horst IC; Hillege HL; Voors AA
Am Heart J; 2012 Nov; 164(5):742-749.e3. PubMed ID: 23137505
[TBL] [Abstract][Full Text] [Related]
30. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients.
Huang M; Que Y; Shen X
J Diabetes Complications; 2015 Apr; 29(3):422-6. PubMed ID: 25659638
[TBL] [Abstract][Full Text] [Related]
32. An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental glomerulosclerosis.
Rhee H; Song SH; Kwak IS; Kim IY; Seong EY; Lee DW; Lee SB
Clin Exp Nephrol; 2012 Aug; 16(4):589-95. PubMed ID: 22302086
[TBL] [Abstract][Full Text] [Related]
33. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
[TBL] [Abstract][Full Text] [Related]
34. Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.
Miura J; Yamamoto Y; Osawa M; Watanabe T; Yonekura H; Uchigata Y; Yamamoto H; Iwamoto Y
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):253-4. PubMed ID: 17185626
[No Abstract] [Full Text] [Related]
35. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
36. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
[TBL] [Abstract][Full Text] [Related]
38. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
[TBL] [Abstract][Full Text] [Related]
39. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
40. Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea.
Cai W; Sun JF; Liu Y; Xu JX; Xiao JR; Duan XM; Liu JY; Zhang W
J Hum Hypertens; 2015 Dec; 29(12):713-8. PubMed ID: 25994997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
